A single injection of the 102-year-old tuberculosis vaccine, BCG, has proven effective at triggering an immune response in mice and shrank their liver cancer tumors, according to research by UC Davis Health. The findings suggest that BCG might be an alternative way of treating this notoriously hard-to-treat cancer.Continue ReadingCategory: Medical, ScienceTags: Cancer, Tumor, Tuberculosis, UC Davis

Who Voted for this Story



Clickiz.com is a social bookmarking place where you can share, find & discuss the best news around on most topics. We focus on hi-tech reviews, gadgets and geekery but we like almost anything that's awesome, appealing and thought-provoking! er6i9ds5mz




Add to Technorati Favorites
Username:

Password:

Remember: